SeekIn Inc is a biotech company founded in early 2018, focusing on blood-based pan cancer early detection utilizing next-generation sequencing and artificial intelligence. Since founded, SeekIn has been committed to providing cutting-edge and cost-effective solutions for cancer early detection, postoperative recurrence monitoring, and treatment response evaluation. SeekIn also developed novel molecular tests for leukemia patients. With its proprietary technical advances, SeekIn has launched a number of research and clinical studies in collaboration with top-tier hospitals in Japan, EU and China.
The management team of SeekIn consists of experts with insightful and complementary experiences in R&D, clinical lab management, business operations, corporate finance, and product commercialization.
I hope that with all our efforts today, when we identify a positive case, the person will say to me, "Dr. Mao, no worries. I just have cancer".
——— Mao Mao
Dr. Mao's TEDxTheBund talk in 2020
multiplex, stepwise, cost-effective blood-based cancer screening
A NGS test to capture cancer genetic features in plasma
To calculate cancer risk score
Non-invasive blood based screening method,10ml blood